As this inhibition of triglyceride transport is rescued in leptin-deficient mice, regulating VLDL metabolism by hepatic VLDLR, LPL, and leptin may represent a new therapeutic strategy for preventing diet-induced liver steatosis. Here, LPL is linked to fatty liver disease.